Chembio Diagnostics names president, EMEA and APAC regions
Robert Passas has joined the company as President, EMEA and APAC regions, with responsibility for commercial operations in Europe, Middle East, Africa, and Asia.
Dr. Passas joins Chembio bringing an established track record and expertise in clinical diagnostics, which includes over 25 years of general management and commercial operations.
Prior to joining the company, he held positions of increasing responsibility at Abbott, Quidel, The Binding Site, and Trinity Biotech. In his most recent position, he was responsible for worldwide marketing and international sales at Trinity Biotech.
Dr. Passas holds a B.S. in medical biochemistry and a Ph.D. in analytical chemistry from the University of Surrey, U.K.
Sharon Klugewicz, most recently the Company's Chief Operating Officer, has been promoted to President, Americas region, with responsibility for commercial operations in the United States, Latin America, and Canada.
Ms. Klugewicz joined Chembio in 2012 and demonstrated success and leadership in multiple roles, including her most recent position as Chief Operating Officer.
Prior to joining the company, she spent 20 years at Pall Corporation where she held positions of increasing responsibility, including Senior Vice President, Scientific and Laboratory Services.
Ms. Klugewicz received a B.S. in Neurobiology from Stony Brook University and a M.S. in Biochemistry from Adelphi University. ■
LATEST MOVES FROM New York
- Barnes & Noble Education appoints Michael P. Huseby as CEO
- Omnicom Group appoints Gracia Martore as director
- Bank of New York names Charles W. Scharf as CEO
- Sterling Bancorp appoints Christina M. Favilla as COO
- Interpublic Group names E. Lee Wyatt Jr. as independent director
More inside POST